Additional Synthetic Drug Testing, 22209 [2013-08752]

Download as PDF Federal Register / Vol. 78, No. 72 / Monday, April 15, 2013 / Proposed Rules (b) Class 3 (Native) oil—a salable quantity of 1,432,189 pounds and an allotment percentage of 61 percent. Dated: April 9, 2013. David R. Shipman, Administrator, Agricultural Marketing Service. [FR Doc. 2013–08681 Filed 4–12–13; 8:45 am] BILLING CODE 3410–02–P NUCLEAR REGULATORY COMMISSION 10 CFR Part 26 [Docket No. PRM–26–8; NRC–2012–0290] Additional Synthetic Drug Testing Nuclear Regulatory Commission. ACTION: Petition for Rulemaking; consideration in the rulemaking process. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) will consider the issues raised in a petition for rulemaking (PRM), PRM–26–8, submitted by Mr. Thomas King (the petitioner) in the NRC’s rulemaking process. The petitioner requested that the NRC amend its Fitness for Duty program regulations to amend drug testing requirements to test for additional synthetic drugs currently not included in the regulations. The NRC determined that the issues raised in the PRM are appropriate for consideration in an ongoing rulemaking on Drug and Alcohol Testing. The NRC is not instituting a public comment period at this time. DATES: The docket for the petition for rulemaking, PRM–26–8, is closed on April 15, 2013. ADDRESSES: Further NRC action on the issues raised by this petition can be found on the Federal rulemaking Web site at https://www.regulations.gov by searching on Docket ID NRC–2012– 0079, which is the rulemaking docket for the Part 26 Drug and Alcohol Testing; Technical Issues and Editorial Changes rulemaking. You can access publicly available documents related to the petition, which the NRC possesses and are publicly available, using any of the following methods: • Federal Rulemaking Web site. Supporting materials related to this petition can be found at https:// www.regulations.gov by searching on the petition Docket ID NRC–2012–0290 or the Part 26 Drug and Alcohol Testing; Technical Issues and Editorial Changes rulemaking Docket ID NRC–2012–0079. mstockstill on DSK4VPTVN1PROD with PROPOSALS SUMMARY: VerDate Mar<15>2010 16:18 Apr 12, 2013 Jkt 229001 Address questions about NRC dockets to Carol Gallagher; telephone: 301–492– 3668; email: Carol.Gallagher@nrc.gov. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may access publicly available documents online in the NRC Library at https://www.nrc.gov/readingrm/adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The petition for rulemaking is available in ADAMS under Accession Number ML12332A137. • NRC’s Public Document Room (PDR): You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Scott Sloan, Office of Nuclear Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 20555; telephone: 301–415–1619; email: Scott.Sloan@nrc.gov. SUPPLEMENTARY INFORMATION: On October 3, 2012, the NRC received a PRM filed by Thomas King requesting the NRC take immediate action to address and curtail the use of new synthetic drugs at nuclear power plants. The NRC requirements in Part 26 of Title 10 of the Code of Federal Regulations (10 CFR), ‘‘Fitness for Duty Program,’’ already enable licensees and other affected entities to add other drugs that are scheduled in the Controlled Substances Act to the panel of substances tested pursuant to 10 CFR 26.31(d)(1)(i). However, the NRC has determined that the broader issue of synthetic drug use raised by the petitioner is appropriate for consideration and will address it in the ongoing 10 CFR part 26 Drug and Alcohol Testing; Technical Issues and Editorial Changes rulemaking. Therefore, the NRC is not instituting an opportunity for public comment at this time. Stakeholders will have an opportunity to comment on the proposed rule associated with 10 CFR part 26 Drug and Alcohol Testing; Technical Issues and Editorial Changes. You can monitor NRC action on the issues raised by this petition by searching on the rulemaking Docket ID NRC–2012–0079 on the Federal rulemaking Web site. This site allows you to receive alerts when changes or additions occur in a docket folder. To subscribe: (1) Navigate to the docket PO 00000 Frm 00008 Fmt 4702 Sfmt 4702 22209 folder (NRC–2012–0079; Part 26 Drug and Alcohol Testing; Technical Issues and Editorial Changes rulemaking); (2) click the ‘‘Email Alert’’ link; and (3) enter your email address and select how frequently you would like to receive emails (daily, weekly, or monthly). The Docket for the petition, PRM–26– 8, is closed. Dated at Rockville, Maryland, this 4th day of April 2013. For the Nuclear Regulatory Commission. R.W. Borchardt, Executive Director for Operations. [FR Doc. 2013–08752 Filed 4–12–13; 8:45 am] BILLING CODE 7590–01–P DEPARTMENT OF TRANSPORTATION Federal Aviation Administration 14 CFR Part 39 [Docket No. FAA–2013–0340; Directorate Identifier 2010–SW–081–AD] RIN 2120–AA64 Airworthiness Directives; Eurocopter Deutschland GmbH Helicopters Federal Aviation Administration (FAA), DOT. ACTION: Notice of proposed rulemaking (NPRM). AGENCY: We propose to adopt a new airworthiness directive (AD) for Eurocopter Deutschland GmbH (Eurocopter) Model EC135 P1, EC135 P2, EC135 P2+, EC135 T1, EC135 T2, EC135 T2+, and MBB–BK 117 C–2 helicopters with a certain external mounted hoist system (hoist) with boom support assembly (boom) installed. This proposed AD would require inspecting the boom for a crack and, if a crack exists, replacing the boom with an airworthy boom. This proposed AD is prompted by cracks found on the boom during a pre-flight check of a hoist on an MBB–BK 117 C–2 helicopter. The proposed actions are intended to detect a crack and prevent failure of the boom, loss of the boom and attached loads, and subsequent loss of helicopter control. DATES: We must receive comments on this proposed AD by June 14, 2013. ADDRESSES: You may send comments by any of the following methods: • Federal eRulemaking Docket: Go to https://www.regulations.gov. Follow the online instructions for sending your comments electronically. • Fax: 202–493–2251. • Mail: Send comments to the U.S. Department of Transportation, Docket Operations, M–30, West Building SUMMARY: E:\FR\FM\15APP1.SGM 15APP1

Agencies

[Federal Register Volume 78, Number 72 (Monday, April 15, 2013)]
[Proposed Rules]
[Page 22209]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-08752]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

10 CFR Part 26

[Docket No. PRM-26-8; NRC-2012-0290]


Additional Synthetic Drug Testing

AGENCY: Nuclear Regulatory Commission.

ACTION: Petition for Rulemaking; consideration in the rulemaking 
process.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will consider the 
issues raised in a petition for rulemaking (PRM), PRM-26-8, submitted 
by Mr. Thomas King (the petitioner) in the NRC's rulemaking process. 
The petitioner requested that the NRC amend its Fitness for Duty 
program regulations to amend drug testing requirements to test for 
additional synthetic drugs currently not included in the regulations. 
The NRC determined that the issues raised in the PRM are appropriate 
for consideration in an ongoing rulemaking on Drug and Alcohol Testing. 
The NRC is not instituting a public comment period at this time.

DATES: The docket for the petition for rulemaking, PRM-26-8, is closed 
on April 15, 2013.

ADDRESSES: Further NRC action on the issues raised by this petition can 
be found on the Federal rulemaking Web site at https://www.regulations.gov by searching on Docket ID NRC-2012-0079, which is 
the rulemaking docket for the Part 26 Drug and Alcohol Testing; 
Technical Issues and Editorial Changes rulemaking.
    You can access publicly available documents related to the 
petition, which the NRC possesses and are publicly available, using any 
of the following methods:
     Federal Rulemaking Web site. Supporting materials related 
to this petition can be found at https://www.regulations.gov by 
searching on the petition Docket ID NRC-2012-0290 or the Part 26 Drug 
and Alcohol Testing; Technical Issues and Editorial Changes rulemaking 
Docket ID NRC-2012-0079. Address questions about NRC dockets to Carol 
Gallagher; telephone: 301-492-3668; email: Carol.Gallagher@nrc.gov.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may access publicly available documents online in the NRC 
Library at https://www.nrc.gov/reading-rm/adams.html. To begin the 
search, select ``ADAMS Public Documents'' and then select ``Begin Web-
based ADAMS Search.'' For problems with ADAMS, please contact the NRC's 
Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-
4737, or by email to pdr.resource@nrc.gov. The petition for rulemaking 
is available in ADAMS under Accession Number ML12332A137.
     NRC's Public Document Room (PDR): You may examine and 
purchase copies of public documents at the NRC's PDR, Room O1-F21, One 
White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Scott Sloan, Office of Nuclear Reactor 
Regulation, U.S. Nuclear Regulatory Commission, Washington, DC 20555; 
telephone: 301-415-1619; email: Scott.Sloan@nrc.gov.

SUPPLEMENTARY INFORMATION: On October 3, 2012, the NRC received a PRM 
filed by Thomas King requesting the NRC take immediate action to 
address and curtail the use of new synthetic drugs at nuclear power 
plants. The NRC requirements in Part 26 of Title 10 of the Code of 
Federal Regulations (10 CFR), ``Fitness for Duty Program,'' already 
enable licensees and other affected entities to add other drugs that 
are scheduled in the Controlled Substances Act to the panel of 
substances tested pursuant to 10 CFR 26.31(d)(1)(i). However, the NRC 
has determined that the broader issue of synthetic drug use raised by 
the petitioner is appropriate for consideration and will address it in 
the ongoing 10 CFR part 26 Drug and Alcohol Testing; Technical Issues 
and Editorial Changes rulemaking. Therefore, the NRC is not instituting 
an opportunity for public comment at this time. Stakeholders will have 
an opportunity to comment on the proposed rule associated with 10 CFR 
part 26 Drug and Alcohol Testing; Technical Issues and Editorial 
Changes.
    You can monitor NRC action on the issues raised by this petition by 
searching on the rulemaking Docket ID NRC-2012-0079 on the Federal 
rulemaking Web site. This site allows you to receive alerts when 
changes or additions occur in a docket folder. To subscribe: (1) 
Navigate to the docket folder (NRC-2012-0079; Part 26 Drug and Alcohol 
Testing; Technical Issues and Editorial Changes rulemaking); (2) click 
the ``Email Alert'' link; and (3) enter your email address and select 
how frequently you would like to receive emails (daily, weekly, or 
monthly).
    The Docket for the petition, PRM-26-8, is closed.

    Dated at Rockville, Maryland, this 4th day of April 2013.

    For the Nuclear Regulatory Commission.
R.W. Borchardt,
Executive Director for Operations.
[FR Doc. 2013-08752 Filed 4-12-13; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.